On October 24, 2024, following the successful launch in Shanghai in September, the 4th Annual 2024 LCOUNCIL Healthcare Industry Legal Compliance Summit made its way to Beijing. The summit, co-hosted by Llinks and industry leaders, aimed to explore new trends and challenges within the healthcare sectors. It featured top legal professionals with experience in the pharmaceutical industry, legal tech companies, benchmarking corporate legal leaders, Chief Compliance Officers, and risk management officers to delve into cutting-edge compliance topics such as anti-unfair competition, data compliance, and pharmaceutical licensing transactions. The summit sought to connect with peers, discuss the future, and contribute to the healthcare industry amidst a complex and changing environment.
Dr. David Pan, a partner at Llinks Law Offices, was invited to participate in the summit and provided an in-depth interpretation and shared his professional insights on the theme of 'Key Issues and Trends in Data Compliance in the Life Sciences and Healthcare Industry'.
Dr. David Pan heads the corporate compliance team at Llinks Law Offices. He is an alumnus of Harvard Law School, where he earned his Master of Laws (LL.M.), and Shanghai Jiao Tong University's KoGuan School of Law, from which he received his Doctor of Jurisprudence. He is admitted to practise law in both China and the state of New York in the United States.
With 22 years of legal experience in China and the United States, Dr. Pan is well-versed in the business cultures and legal systems of both countries. He has worked at two renowned Chinese law firms and served as General Counsel at a well-known multinational corporation. Dr. Pan has handled complex transactions for domestic and foreign investors and institutions, including mergers and acquisitions, joint ventures, foreign direct investment, strategic alliances, cross-border transactions, technology licensing and franchising, and bulk commodity transactions. His clientele spans a range of industries, including healthcare, pharmaceuticals, automotive, investment, energy, chemicals, internet, food, manufacturing, culture and sports, consumer goods, and real estate.
Dr. Pan excels at providing efficient and practical compliance legal services in the areas of anti-monopoly and anti-corruption for businesses operating in cross-border environments. He has served numerous well-known automotive, manufacturing, and retail enterprises on competition law compliance and business compliance policy formulation and implementation, internal training and investigations, crisis management, and third-party compliance management. Dr. Pan has been recognised as a recommended lawyer in the fields of corporate, compliance, anti-monopoly, and competition law by Chambers, The Legal 500, LEGALBAND, and Who's Who Legal.
Beyond traditional compliance services, Dr. Pan has been providing legal services for corporate server overseas setup, data logging, personal information collection and use, data integrity, and centralised data processing for many years. Through years of practice, he has accumulated extensive experience in the field of cybersecurity and data privacy. Dr. Pan has led his team to establish or improve compliance systems for over a hundred enterprises in healthcare, internet, automotive, tourism, e-commerce, retail, education, services, finance, and advanced manufacturing for the entire process of data collection, storage, use, transfer, and destruction, providing compliance solutions for digital marketing, digital transformation, data transactions, and cybersecurity reviews. From 2019 to 2024, Dr. Pan has been rated as a leading lawyer in China for cybersecurity and data protection by LEGALBAND for six consecutive years. From 2020 to 2024, he has been recognised as a leading lawyer in data and privacy protection in China by Chambers, The Legal 500, and ALB. From 2019 to 2023, the team led by Dr. Pan has been rated as a leading service team for cybersecurity and privacy protection in China by China Business Law Journal and The Legal 500. In 2020 and 2023, Dr. Pan was nominated as the 'Leading Lawyer in Data Privacy Protection in Asia' by ALB.
Dr. Pan serves as a visiting professor/adjunct instructor at Shanghai Jiao Tong University's KoGuan Law School, Director of the Data Compliance and Cybersecurity Committee of the Shanghai Bar Association, review expert at the Shanghai United Assets and Property Exchange, and a third-party supervisory expert for the compliance non-prosecution pilot project in the China (Shanghai) Pilot Free Trade Zone.
In 2024, as the global economy recovers and public health awareness increases, the healthcare industry is undergoing profound changes. Thanks to national policy support, technological innovation, market demand expansion, and the deepening of globalization strategies, China's healthcare industry has achieved significant upgrades. Although the investment atmosphere is becoming more cautious and global pharmaceutical companies face increasingly severe challenges on the international stage, the importance of legal compliance in the medical and pharmaceutical industry is becoming more prominent against the backdrop of new environments, new business forms, and new markets, becoming an indispensable part of corporate operations. In the future, Llinks will integrate more deeply into the operations of medical and pharmaceutical companies, providing solid legal protection for their compliant operations and development.
